Skip to main content
. Author manuscript; available in PMC: 2023 Oct 4.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2022 Oct 4;15(10):e008995. doi: 10.1161/CIRCOUTCOMES.122.008995

Figure 3: Differences in individual goal attainment between chronic kidney disease groups.

Figure 3:

Figure 3a. Differences in probability of guideline-directed medical therapy (GDMT) goal attainment and 95% credible intervals at 24m for chronic kidney disease (CKD) G5D versus CKD G4–5. Estimates are displayed under two separate assumptions for missing values: missing at random (MAR) and missing not at random according to a pattern mixture model (PMM) approach. For example, compared to CKD G4–5, CKD G5D were approximately 7 percentage points less likely to receive statin therapy by 24 months. 95% CrI: 95% credible interval; LDL: low density lipoprotein; SBP: systolic blood pressure.